Vitamin K is a group of fat-soluble compounds required primarily for the normal activation of several proteins involved in blood coagulation and bone metabolism. Naturally occurring forms include phylloquinone, commonly designated K1, which is abundant in green leafy vegetables, and menaquinones, collectively designated K2, which include several forms produced by bacteria and present in some fermented and animal-derived foods. Vitamin K functions as a cofactor for an enzyme system that adds gamma-carboxyl groups to specific glutamate residues in target proteins.
This post-translational modification allows particular proteins to bind calcium effectively and become biologically functional. Vitamin K is therefore essential for normal haemostasis, but its role is not limited to preventing bleeding; it also contributes to the activation of proteins involved in skeletal and vascular biology. Its fat-soluble nature means absorption is linked to dietary fat and normal gastrointestinal function, and its metabolism differs substantially from that of water-soluble vitamins.
The central biochemical process associated with Vitamin K is the vitamin K cycle. During gamma-carboxylation, reduced vitamin K is oxidised to a vitamin K epoxide form, which is then recycled to an active reduced state through enzymes including vitamin K epoxide reductase. This recycling allows relatively small amounts of vitamin K to support repeated enzymatic reactions.
Several clotting proteins, including prothrombin and factors VII, IX and X, require vitamin K-dependent carboxylation, as do regulatory anticoagulant proteins such as proteins C and S. The result is a finely regulated haemostatic system rather than a simple "clot-promoting" effect. Vitamin K is therefore necessary for both procoagulant and anticoagulant proteins, and its biological role is better described as enabling proper maturation of the coagulation system than as simply making blood clot more readily.
Vitamin K deficiency can impair the activation of clotting proteins and increase bleeding tendency. Clinically significant deficiency is uncommon in healthy adults eating varied diets but can occur when fat absorption is severely impaired, dietary intake is extremely inadequate or certain medications interfere with vitamin K metabolism. Newborn infants have relatively low vitamin K stores, limited placental transfer and a developing intestinal microbial environment, creating a recognised risk of vitamin K deficiency bleeding.
This is why neonatal vitamin K prophylaxis is routinely offered in many healthcare systems. Infants who develop severe deficiency can experience potentially serious bleeding, including intracranial bleeding. The prevention strategy is an important practical example of how a micronutrient can have a critical physiological role despite being required in relatively small quantities.
Vitamin K has a direct relationship with anticoagulant therapy involving drugs that inhibit vitamin K recycling. Warfarin is the classic example: it inhibits vitamin K epoxide reductase, reducing the availability of active vitamin K and thereby decreasing activation of vitamin K-dependent clotting proteins. Patients taking warfarin therefore need consistent vitamin K intake rather than necessarily avoiding vitamin K-containing foods completely, because large fluctuations in intake can alter anticoagulant response. This illustrates a broader principle that nutrients can interact pharmacologically with medicines. Vitamin K supplementation or major dietary changes should consequently be discussed with the relevant healthcare professional when someone is receiving vitamin K-antagonist therapy.
Vitamin K also participates in the biology of bone through activation of proteins such as osteocalcin and matrix Gla protein. Osteocalcin is produced by bone-forming cells and requires vitamin K-dependent carboxylation for full functional activity, while matrix Gla protein is involved in regulating mineralisation in tissues. These mechanisms have generated interest in vitamin K supplementation for bone and vascular health.
However, mechanistic plausibility does not by itself demonstrate that high-dose supplementation prevents fractures or vascular disease in people who already have adequate vitamin K status. Research into different forms of vitamin K, particularly various menaquinones, continues to investigate possible clinical effects, but nutritional requirements should not be confused with claims that pharmacological doses are universally beneficial.
Dietary Vitamin K1 is especially abundant in leafy green vegetables such as kale, spinach and other dark green plants. Because K1 is associated with chlorophyll and plant tissues, vegetable consumption can make a substantial contribution to intake. K2 forms are chemically diverse and can occur in fermented foods and animal-derived products, while some intestinal bacteria produce menaquinones.
The extent to which bacterial production makes a major contribution to human vitamin K requirements remains complex and depends on the form produced, location and absorption. Vitamin K absorption is influenced by dietary fat and gastrointestinal function. People with disorders causing fat malabsorption may therefore be at greater risk of deficiency even when their food intake appears reasonable.
Vitamin K is sometimes incorrectly characterised as a single compound or as a substance whose only purpose is coagulation. In reality, the term describes a family of related compounds with different chemical structures and sources, and its biochemical function involves activation of several distinct proteins. It should also be distinguished from the concept of "blood thickening": adequate vitamin K does not simply make blood excessively coagulable, because vitamin K is required for a regulated network containing both clot-promoting and anticoagulant proteins. Another misconception is that all forms of vitamin K have identical nutritional and pharmacological behaviour. Their absorption, tissue distribution, half-lives and evidence bases differ, making form-specific interpretation important.
Vitamin K is therefore best understood as a fat-soluble family of cofactors whose defining biochemical function is gamma-carboxylation of specific proteins. Its importance is most immediately visible in normal coagulation, but its actions extend to proteins involved in bone and mineral regulation. Deficiency is unusual in healthy adults but can become clinically important in malabsorption and infancy, while medication interactions make vitamin K particularly relevant to people receiving vitamin K-antagonist anticoagulants. The distinction between K1 and K2, between nutritional adequacy and supplementation, and between enabling coagulation proteins and simply "causing clotting" provides the key conceptual framework for understanding Vitamin K.
